Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...
Radiofrequency-based ablation for atrial fibrillation appears more effective than previously shown in clinical trials. Using real-world data, a new study found that the procedure eliminated atrial ...
Radiofrequency ablation (RFA) is a minimally invasive treatment that can sometimes relieve chronic back pain. During the procedure, a doctor inserts a thin metal probe into the painful area. The probe ...
Temperature-Controlled Radiofrequency Ablation Shows Lasting Benefits for Chronic Rhinitis Treatment
Among patients with chronic rhinitis, temperature-controlled radiofrequency ablation of the posterior nasal nerve provided sustained reduction in symptoms, according to a study of 3-year follow-up ...
Radiofrequency ablation is a minimally invasive procedure that doctors use for pain management and to shrink the size of cancerous tumors, nodules, and other growths. It is a procedure that uses ...
Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.
Mayo Clinic study leads to Food and Drug Administration approval of radio-frequency ablation for treatment of cancer pain in bone What: An international clinical study led by Mayo Clinic in Rochester, ...
Please provide your email address to receive an email when new articles are posted on . AF recurrence after pulsed field ablation was comparable vs. after radiofrequency ablation. There were fewer ...
Please provide your email address to receive an email when new articles are posted on . Radiofrequency ablation reduced tumor size in patients with papillary thyroid carcinoma at 12 months. Ablation ...
Data that guide selection of optimal local ablative therapy for the management localized hepatocellular carcinoma (HCC) are lacking. Because there are limited prospective comparative data for these ...
Docetaxel (Do) and gemcitabine (Gem) in advanced pancreatic cancer (APC) patients (pts): A multicentre study No significant financial relationships to disclose. This is an ASCO Meeting Abstract from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results